(Q81969844)
Statements
Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancer (English)
Sylvie Négrier
David Perol
Jacques O Bay
Stéphane Oudard
Sylvie Chabaud
Pierre Fargeot
Remy Delva
Gael Deplanque
Gwenaelle Gravis
Bernard Escudier
French Immunotherapy Group
1 September 2008